Genflow Biosciences plc (LON: GENF) (OTCQB: GENFF) is an emerging leader in the field of longevity research with R&D facilities in Belgium and a U.S. office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the aging process in humans and dogs. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results. Managed by an experienced team with decades of experience in the pharmaceutical and biotechnology sectors, the company is optimistic that development programs will continue at pace in the next 24 months.
| Website | http://www.genflowbio.com |
| Employees | 7 (3 on RocketReach) |
| Founded | 2020 |
| Phone | +1 617-863-5500 |
| Technologies |
JavaScript
,
HTML
,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Biopharma, Biotechnology, Aging Research, Senolytics, Longevity, Geroscience, Pharmaceutical Research, Drug Discovery, Therapeutic Development, Clinical Trials, Gene Therapy, Regenerative Medicine, Biomarkers, Molecular Biology, Anti-Aging Therapies, Healthspan, Life Extension, Stem Cell Research |
| Competitors | Novo Nordisk, The National Institutes of Health, GRAIL, Synthego Corporation, Seres Therapeutics, Telesis Bio, Cynata Therapeutics, INDIGO Biosciences, INC, Helomics, Millennium Health Group, PC +35 more (view full list) |
Looking for a particular GenFlow Biosciences employee's phone or email?
GenFlow Biosciences Questions
Guy-Charles de la Horie is the Board Member of GenFlow Biosciences.
3 people are employed at GenFlow Biosciences.
Top GenFlow Biosciences Employees
Related Companies
